Stem cells therapy are emerging as an important therapeutic option in the field of cartilage regeneration. Rapid development of stem cell-based therapy for cartilage regeneration in the recent past has been witnessed across the world. Stem cells are mainly classified in three kinds of cells: hematopoietic stem cell, mesenchymal stem cells, and pluripotent stem cells.

The global stem cell cartilage regeneration market size was valued at US$ 254.4 million in 2017, and is expected to witness a CAGR of 8.9% over the forecast period (2018 – 2026).

Stem cell therapy for knees, minimally invasive procedure, has the potential to decrease inflammation, halt progression of arthritic damage, repair joint cartilage, and delay or avoid knee replacement surgery. Injection of progenitor cells, especially mesenchymal stem cells (MSCs), has been found to be an effective and better solution for repairing degenerative cartilage compared to implantation of differentiated cells such as articular cartilage.

In addition to this, other potential benefits such as lower risk and shorter duration of minimally invasive surgery procedures are expected to fuel demand for stem cell therapy for cartilage regeneration during the forecast period. For instance, according to NCBI 2016 report, a minimally invasive procedure to harvest stem cells from both fat and bone marrow and inject the concentrated cells under image guidance can be performed in 2-3 hours.

Stem Cell Cartilage Regeneration Market Restraints

Stem cell therapy for cartilage damage is associated with high treatment costs. According to the Journal of Cell Science & Therapy 2017 article, stem cell therapy range from US$ 5,000 to US$ 8,000 per treatment. In the U.S., the one-time treatment, which utilizes blood drawn from a patient can cost as little as US$ 1,500. However, additional protocols that utilize a bone marrow or adipose tissue extraction for stem cells can cost as much as US$ 15,000 to US$ 30,000. Moreover, the bone marrow extraction is an invasive procedure, which requires bone penetration and adipose tissue extraction, necessitates a medical professional trained in liposuction. These challenges are expected to hamper the adoption of stem cell in cartilage regeneration, during the forecast period.

Stem Cell Cartilage Regeneration Market - Regional Insights

On the basis of region, the global stem cell cartilage regeneration market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be the most conducive region for growth of the stem cell cartilage regeneration market over the forecast period, due to high presence of key players in the region. Key players such as Vericel Corporation, Osiris Therapeutics, among others are focusing on various growth strategies such as gaining regulatory product approvals and launching innovative stem cell based cartilage regeneration products and technologies in the market.

Furthermore, increasing geriatric population, which is more prone to degenerative disorders such as osteoarthritis among the U.S. population, is further expected to propel growth of the stem cell cartilage regeneration market. For instance, according to Centers for Disease Control and Prevention (CDC), July 2018 data findings, from 2013-2015, an estimated 54.4 million U.S. adults (22.7% of total U.S. population) annually suffers from some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia.

In cartilage regeneration, stem cells have the potential for multiple differentiation and self-replication, making it an ideal choice for use as seed cells. Growing regenerative medicine industry and increasing demand for stem cells in the development of various types of cell therapies are expected to drive growth of the market over the forecast period. Mesenchymal stem cells are the most widely applied stem cells in the field of cartilage regeneration.

Market Dynamics

Growing osteoarthritis incidence among the global population is supporting the adoption of stem cell cartilage regeneration therapy. For instance, according to November 2017, Arthritis Foundation data findings, with the increase in global geriatric population, degenerative disease disorders such as osteoarthritis will impact at least 130 million individuals around the globe by 2050.

Furthermore, various government agencies are focusing on policies to enhance adoption of stem cell therapies, which is expected to drive growth of stem cell cartilage regeneration market in the near future. For instance, in December 2016, the 21st Century Cures Act (Cures Act) was signed into law by the U.S. FDA, thereby allowing legislation for an expedited approval path for cellular medicines designated as regenerative medicine advanced therapies (RMATs) to patients who are in need of it.

However, high cost of treatment is expected to hamper the stem cell cartilage regeneration market during the forecast period. Moreover, extensive time and expertise required to perform stem cell based therapy leads to increase the cost of this procedure. In some cases, the physician must pay licensing fees to access stem cell sourcing, processing, or delivering these technologies.

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics

The global stem cell cartilage regeneration market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for stem cell cartilage regeneration market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Stem Cell Cartilage Regeneration Market, By Stem Cell Type:

Hematopoietic Stem Cells (HSCs)

Pluripotent Stem Cells (iPSC/ESCs)

Mesenchymal Stem Cells (MSCs)

Global Stem Cell Cartilage Regeneration Market, By Treatment:

Microfracture

Osteochondral Transplant

Autologous Chondrocyte Implantation

Stem Cell Injections

Global Stem Cell Cartilage Regeneration Market, By End User:

Hospitals & Clinics

Ambulatory Surgical Centers

Global Stem Cell Cartilage Regeneration Market, By Region:

North America

By Country:

U.S.

Canada

By Stem Cell Type:

Hematopoietic Stem Cells (HSCs)

Pluripotent Stem Cells (iPSC/ESCs)

Mesenchymal Stem Cells (MSCs)

By Treatment:

Microfracture

Osteochondral Transplant

Autologous Chondrocyte Implantation

Stem Cell Injections

By End User:

Hospitals & Clinics

Ambulatory Surgical Centers

Europe

By Country:

U.K.

Germany

Italy

Spain

France

Russia

Rest of Europe

By Stem Cell Type:

Hematopoietic Stem Cells (HSCs)

Pluripotent Stem Cells (iPSC/ESCs)

Mesenchymal Stem Cells (MSCs)

By Treatment:

Microfracture

Osteochondral Transplant

Autologous Chondrocyte Implantation

Stem Cell Injections

By End User:

Hospitals & Clinics

Ambulatory Surgical Centers

Asia Pacific

By Country:

Australia

India

China

Japan

ASEAN

South Korea

Rest of Asia Pacific

By Stem Cell Type:

Hematopoietic Stem Cells (HSCs)

Pluripotent Stem Cells (iPSC/ESCs)

Mesenchymal Stem Cells (MSCs)

By Treatment:

Microfracture

Osteochondral Transplant

Autologous Chondrocyte Implantation

Stem Cell Injections

By End User:

Hospitals & Clinics

Ambulatory Surgical Centers

Latin America

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

By Stem Cell Type:

Hematopoietic Stem Cells (HSCs)

Pluripotent Stem Cells (iPSC/ESCs)

Mesenchymal Stem Cells (MSCs)

By Treatment:

Microfracture

Osteochondral Transplant

Autologous Chondrocyte Implantation

Stem Cell Injections

By End User:

Hospitals & Clinics

Ambulatory Surgical Centers

Middle East

By Country:

GCC

Israel

Rest of Middle East

By Stem Cell Type:

Hematopoietic Stem Cells (HSCs)

Pluripotent Stem Cells (iPSC/ESCs)

Mesenchymal Stem Cells (MSCs)

By Treatment:

Microfracture

Osteochondral Transplant

Autologous Chondrocyte Implantation

Stem Cell Injections

By End User:

Hospitals & Clinics

Ambulatory Surgical Centers

Africa

By Country:

South Africa

Central Africa

North Africa

By Stem Cell Type:

Hematopoietic Stem Cells (HSCs)

Pluripotent Stem Cells (iPSC/ESCs)

Mesenchymal Stem Cells (MSCs)

By Treatment:

Microfracture

Osteochondral Transplant

Autologous Chondrocyte Implantation

Stem Cell Injections

By End User:

Hospitals & Clinics

Ambulatory Surgical Centers

Company Profiles

Theracell Advanced Biotechnology Ltd.*

Company Overview

Product Portfolio

Financial Performance

Recent Highlights

Strategies

Orthocell Ltd.

Xintela AB

CellGenix GmbH

Merck KGaA

Osiris Therapeutics, Inc.

BioTissue SA

Vericel Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

Primary Research (Trade Surveys and Experts Interviews)

Desk Research

Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Coherent Market Insights desk research is based on a principle set of research techniques:

National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.

Trade association, National and international media and trade press.

Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.

Scientific journals, and other technical magazines and whitepapers.

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

Micro-economic indicators

Macro-economic indicators

Environmental indicators

Socio-political indicators

Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

It provides first-hand information on the market dynamics, outlook, and growth parameters.

Industry experts validates the estimates which helps the company to cement the on-going research study.